Daniel Tesfa

Daniel Tesfa is a seasoned medical professional with extensive experience in hematology and oncology. Currently serving as Senior Medical Director at Hansa Biopharma since August 2023, Daniel previously held the position of Chief Medical Officer at Vivesto from July 2022 to July 2023. Prior roles include Medical Director in Clinical and Translation Medicine for Hematology at Sobi from June 2020 to July 2022, and Head of Oncology and Hematology in Medical Affairs for Scandinavian operations at Bayer Pharmaceuticals from May 2018 to May 2020. Daniel's career also features significant roles at Roche and Karolinska Universitetssjukhuset, where Daniel advanced from Resident Physician to Senior Consultant. Daniel's educational background includes an MD and PhD from Lund University and Karolinska Institutet, specializing in Internal Medicine and Hematology with additional oncology training.